{"id":"W4386565810","doi":"10.1016/s2213-2600(23)00297-7","title":"Advancing the pipeline of cystic fibrosis clinical trials: a new roadmap with a global trial network perspective","year":2023,"lang":"en","type":"review","venue":"The Lancet Respiratory Medicine","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Heart, Lung, and Blood Institute; NIHR Imperial Biomedical Research Centre; National Center for Advancing Translational Sciences; Medical Research Council; Bundesministerium für Gesundheit; Canadian Institutes of Health Research; National Institutes of Health; National Health and Medical Research Council; Engineering and Physical Sciences Research Council; Institut National de la Santé et de la Recherche Médicale; Deutsche Forschungsgemeinschaft; Bundesministerium für Bildung und Forschung; Insmed; CSL Behring; National Institute for Health and Care Research; Cystic Fibrosis Trust; Chiesi Farmaceutici; LifeArc; Vertex Pharmaceuticals; Chiesi USA; National Institute of Diabetes and Digestive and Kidney Diseases; Sanofi; Gilead Sciences; Genentech; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Clinical trial; Medicine; Population; Cystic fibrosis transmembrane conductance regulator; Disease; Intensive care medicine; Bioinformatics; Pathology; Internal medicine; Biology; Environmental health","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07096563,0.002466444,0.009471445,0.005794382,0.001276007,0.01259836,0.004359859,0.01142064,0.01298627],"category_scores_gemma":[0.0863833,0.001123878,0.004568486,0.004814511,0.0048865,0.02261693,0.006756711,0.01978142,0.003974961],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00933534,"about_ca_system_score_gemma":0.03829829,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00528679,"about_ca_topic_score_gemma":0.01017657,"domain_scores_codex":[0.9757474,0.01408452,0.002766728,0.001208333,0.004934235,0.001258794],"domain_scores_gemma":[0.8393753,0.1247474,0.007944392,0.002483686,0.01836019,0.007089161],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000740934,0.0001468847,0.0003404435,0.04033161,0.0008169324,0.0001756547,0.0002593184,0.001105041,0.0004991006,0.05581092,0.1916289,0.7081444],"study_design_scores_gemma":[0.0008443383,0.0004208575,0.0007677387,0.06432033,0.001229474,0.000364643,0.0003823407,0.0008828591,0.0001378685,0.07133128,0.8592123,0.0001058475],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00007206617,0.9119546,0.001225439,0.0822224,0.003333363,0.0000526582,0.00007764667,0.00007379142,0.0009881157],"genre_scores_gemma":[0.002734425,0.9432356,0.005143199,0.03905481,0.008759085,0.0001936351,0.0001769974,0.00004815903,0.0006541297],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.07096563,"threshold_uncertainty_score":0.3753066,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3386867880027096,"score_gpt":0.546564949404477,"score_spread":0.2078781614017674,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}